Flagship Biosciences is a quantitative pathologyservices organization that combines pathology, image analysis, and regulatory experience to deliver tissue-based biomarkers and companion diagnostics development to pharmaceutical and biotech clients. Flagship provides quantitative approaches to immunohistochemistry and immunofluorescence, with all services supervised by veterinary
Visit Website >

Horizon Discovery is a translational genomics and personalized medicine company founded in June 2007 and is headquartered at IQ Cambridge, Cambridge, U.K., and with additional research laboratories in Torino, Italy. Horizon's goal is to convert new information on the genetic causes of cancer into laboratory models that will facilitate the discovery of drugs that target these defects. 
Visit Website >

Imaging Endpoints Imaging Endpoints is a full-service Imaging Contract Research Organization providing services to the pharmaceutical and medical device industries to accelerate their national and international oncology clinical trials. Extensive expertise in Cancer Imaging allows Imaging Endpoints to perform qualitative and quantitative assessments of both anatomic and physiologic/metabolic imaging modalities in order to evaluate the effectiveness of new therapeutics. 
Visit Website >

Scottsdale Health Care  
Visit Website >

Study Log Study Log provides animal study management solutions to commercial and academic research organizations. Studylog enables organizations to efficiently manage study conduct and study data within a searchable and accessible framework. Organizations can now centrally store and index the institutional knowledge that usually resides in notebooks and the memories of individual researchers. 
Visit Website >

The Translational Genomics Research Institute (TGen The Translational Genomics Research Institute (TGen) is a non-profit 501(c)(3) organization focused on developing earlier diagnostics and smarter treatments. TGen is on the cutting edge of translational research where investigators are able to unravel the genetic components of common and complex diseases. Working with collaborators in the scientific and medical communities, TGen believes it can make a substantial contribution to the efficiency and effectiveness of the translational process. 
Visit Website >